Clinical trial / 2014
Calcium supplementation reduced bone resorption during pregnancy and early postpartum in Mexican women.
In a randomized trial of 670 pregnant Mexican women, taking 1,200 mg per day of calcium reduced urinary N-telopeptides by 15.8% compared to placebo (p < 0.001). Greater pill compliance led to larger reductions in bone resorption up to 22.1% (p < 0.001). Calcium also produced a lower ratio of bone resorption to formation at one month postpartum (p = 0.04).
- Study type
- Randomized controlled trial
- Who was studied
- 670 pregnant women, Mexico
- What was measured
- Urinary cross-linked N-telopeptides of type I collagen, bone-specific alkaline phosphatase, and quantitative ultrasound
THE PAPER
Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican women.
Ettinger AS, Lamadrid-Figueroa H, Mercado-García A, Kordas K, Wood RJ, Peterson KE, Hu H, Hernández-Avila M, Téllez-Rojo MM. Nutr J, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.